Buttgereit, Frank

Dose-related patterns of glucocorticoid-induced side effects

Huscher, D., Thiele, K., Gromnica-Ihle, E., Hein, G., Demary, W., Dreher, R., Zink, A., & Buttgereit, F. (2009) · Annals of the Rheumatic Diseases

Rheumatoid Arthritis Research and TherapiesAdrenal Hormones and Disorders

Cited by 604

Genomic and nongenomic effects of glucocorticoids

Stahn, C., & Buttgereit, F. (2008) · Nature Clinical Practice Rheumatology

Estrogen and related hormone effectsAdrenal Hormones and Disorders

Cited by 594

Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology

Buttgereit, F., Da Silva, J. A. P., Boers, M., Burmester, G.-R., Cutolo, M., Jacobs, J., Kirwan, J., Köhler, L., van Riel, P., Vischer, T., et al. (2002) · Annals of the Rheumatic Diseases

Rheumatoid Arthritis Research and TherapiesAdrenal Hormones and Disorders

Cited by 544

Quantitating Protein Synthesis, Degradation, and Endogenous Antigen Processing

Princiotta, M. F., Finzi, D., Qian, S.-B., Gibbs, J., Schuchmann, S., Buttgereit, F., Bennink, J. R., & Yewdell, J. W. (2003) · Immunity

Immunotherapy and Immune ResponsesUbiquitin and proteasome pathways

Cited by 521

Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists

Stahn, C., Löwenberg, M., Hommes, D. W., & Buttgereit, F. (2007) · Molecular and Cellular Endocrinology

Estrogen and related hormone effectsAdrenal Hormones and Disorders

Cited by 419

Energy regulation and neuroendocrine–immune control in chronic inflammatory diseases

Straub, R. H., Cutolo, M., Buttgereit, F., & Pongratz, G. (2010) · Journal of Internal Medicine

Adipokines, Inflammation, and Metabolic DiseasesRegulation of Appetite and Obesity

Cited by 382

Metabolic regulation of inflammation

Gaber, T., Strehl, C., & Buttgereit, F. (2017) · Nature Reviews Rheumatology

Immune cells in cancerImmune Response and Inflammation

Cited by 320

Glucocorticoids—All-Rounders Tackling the Versatile Players of the Immune System

Strehl, C., Ehlers, L., Gaber, T., & Buttgereit, F. (2019) · Frontiers in Immunology

Adrenal Hormones and DisordersEstrogen and related hormone effects

Cited by 308

European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations

Löhr, J., Beuers, U., Vujasinovic, M., Alvaro, D., Frøkjær, J. B., Buttgereit, F., Capurso, G., Culver, E. L., de‐Madaria, E., Della‐Torre, E., et al. (2020) · United European Gastroenterology Journal

IgG4-Related and Inflammatory DiseasesPancreatitis Pathology and Treatment

Cited by 252

Molecular mechanisms of glucocorticoid-induced osteoporosis.

Patschan, D., Loddenkemper, K., & Buttgereit, F. (2001) · Bone

Bone health and osteoporosis researchBone Metabolism and Diseases

Cited by 201

Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial

Boers, M., Hartman, L., Opris-Belinski, D., Bos, R., Kok, M. R., Da Silva, J. A., Griep, E. N., Klaasen, R., Allaart, C. F., Baudoin, P., et al. (2022) · Annals of the Rheumatic Diseases

Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research

Cited by 169

Signaling Takes a Breath – New Quantitative Perspectives on Bioenergetics and Signal Transduction

Krauss, S., Brand, M. D., & Buttgereit, F. (2001) · Immunity

Metabolism, Diabetes, and CancerCancer, Hypoxia, and Metabolism

Cited by 147

Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial

Burmester, G. R., Buttgereit, F., Bernasconi, C., Álvaro-Gracia, J. M., Castro, N., Dougados, M., Gabay, C., van Laar, J. M., Nebesky, J. M., Pethoe-Schramm, A., et al. (2020) · The Lancet

Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders Research

Cited by 128

Optimized glucocorticoid therapy: teaching old drugs new tricks

Strehl, C., & Buttgereit, F. (2013) · Molecular and Cellular Endocrinology

Estrogen and related hormone effectsAdrenal Hormones and Disorders

Cited by 118

Exogenous and endogenous glucocorticoids in rheumatic diseases

Buttgereit, F., Burmester, G., Straub, R. H., Seibel, M. J., & Zhou, H. (2011) · Arthritis & Rheumatism

Rheumatoid Arthritis Research and TherapiesAdrenal Hormones and Disorders

Cited by 105

Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritis

Westhoff, G., Buttgereit, F., Gromnica-Ihle, E., & Zink, A. (2008) · Rheumatology

Rheumatoid Arthritis Research and TherapiesRetirement, Disability, and Employment

Cited by 66

Adaptation of Human CD4+ T Cells to Pathophysiological Hypoxia: A Transcriptome Analysis

GABER, T., HÄUPL, T., SANDIG, G., TYKWINSKA, K., FANGRADT, M., TSCHIRSCHMANN, M., HAHNE, M., DZIURLA, R., EREKUL, K., LAUTENBACH, M., et al. (2009) · The Journal of Rheumatology

Rheumatoid Arthritis Research and TherapiesCancer, Hypoxia, and Metabolism

Cited by 47

Energy metabolism and rheumatic diseases: from cell to organism

Spies, C. M., Straub, R. H., & Buttgereit, F. (2012) · Arthritis Research & Therapy

Rheumatoid Arthritis Research and TherapiesImmune cells in cancer

Cited by 47

Human CD4+Tcells maintain specific functions even under conditions of extremely restricted ATP production

Tripmacher, R., Gaber, T., Dziurla, R., Häupl, T., Erekul, K., Grützkau, A., Tschirschmann, M., Scheffold, A., Radbruch, A., Burmester, G., et al. (2008) · European Journal of Immunology

T-cell and B-cell ImmunologyCancer, Hypoxia, and Metabolism

Cited by 46

Low‐dose glucocorticoid therapy in rheumatoid arthritis: an obligatory therapy

Bijlsma, J. W. J., van der Goes, M. C., Hoes, J. N., Jacobs, J. W. G., Buttgereit, F., & Kirwan, J. (2010) · Annals of the New York Academy of Sciences

Rheumatoid Arthritis Research and TherapiesNatural Compounds in Disease Treatment

Cited by 31